https://orcid.org/0000-0002-8258-4382
Citations (24)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (24)
Roberto Gabbiadini, Arianna Dal Buono, Elisabetta Mastrorocco, Virginia Solitano, Alessandro Repici, Antonino Spinelli, Gianluigi Condorelli & Alessandro Armuzzi. (2023) Atherosclerotic cardiovascular diseases in inflammatory bowel diseases: to the heart of the issue. Frontiers in Cardiovascular Medicine 10.
Crossref
Crossref
Jasmijn A M Sleutjes, C Janneke van der Woude, P J Pepijn Verploegh, Elif Aribas, Maryam Kavousi, Jeanine E Roeters van Lennep & Annemarie C de Vries. (2023) Cardiovascular risk profiles in patients with inflammatory bowel disease differ from matched controls from the general population. European Journal of Preventive Cardiology.
Crossref
Crossref
Ronak Patel, Ruth Ann Marrie, Charles N. Bernstein, James M. Bolton, Lesley A. Graff, James J. Marriott, Chase R. Figley, Jennifer Kornelsen, Erin L. Mazerolle, Md Nasir Uddin, John D. Fisk, James Bolton, Lesley Graff, Jennifer Kornelsen, Erin Mazerolle, Ronak Patel, Teresa D. Figley & Carl A. Helmick. (2023) Vascular comorbidity is associated with decreased cognitive functioning in inflammatory bowel disease. Scientific Reports 13:1.
Crossref
Crossref
M. A. Isaikina, G. O. Isaev, E. S. Pyatigorets, M. A. Yurazh & O. Iu. Mironova. (2023) Ulcerative colitis and cardiovascular disease. Case report. Systemic Hypertension 19:4, pages 53-57.
Crossref
Crossref
A. Yu. Ryabova, I. V. Kozlova, T. G. Shapovalova & M. M. Shashina. (2022) Comorbidity of gastroenterological and cardiovascular pathology as a problem of clinical practice. Experimental and Clinical Gastroenterology:3, pages 107-114.
Crossref
Crossref
Mohamed Mansoor, Oliver Hamer, Emily Walker & James Hill. (2022) Antibiotics for the secondary prevention of coronary heart disease. British Journal of Cardiac Nursing 17:10, pages 1-7.
Crossref
Crossref
Jasmijn A. M. Sleutjes, Jeanine E. Roeters van Lennep & Annemarie C. de Vries. (2022) Spotlight on Cardiovascular Risk Assessment in Patients with Inflammatory Bowel Disease. Digestive Diseases and Sciences 67:9, pages 4326-4329.
Crossref
Crossref
Lucas Guillo, Aurélien Amiot, Mélanie Serrero, Romain Altwegg, Xavier Roblin, Calina Atanasiu, Anthony Buisson, Catherine Le Berre, Catherine Reenaers, Jean-Marc Gornet, David Laharie, Vered Abitbol, Amélie Biron, Bénédicte Caron, Stéphane Nancey, Antoine Chupin, Antoine Blain, Lucine Vuitton, Ludovic Caillo, Julien Kirchgesner, Maria Nachury, Laurent Peyrin-Biroulet, Benjamin Pariente, Laurent Beaugerie, Phillipe Seksik, Anne Bourrier, Arnaud Bourrreille, Ariadne Desjeux, Guillaume Savoye, Stéphanie Auzou, Guillaume Cadiot, Alban Benezech, Nicolas Mathieu, Georgia Malamut, Karine Amouriaux, Hédia Brixi, Marion Simon, Daniel Benitah, Philippe Ah-Soune, Mathurin Fumery, Gilles Boschetti, Claire Gay, Mathias Vidon, Ginette Fotsing, Benoit Coffin, Cyrielle Gilletta, Jean Marie Reimund & Marie Bonnet-Dodel. (2022) Prevalence of Self-Reported Venous Thromboembolism and Cardiovascular Risk Factors in Patients with Ulcerative Colitis: The GETAID FOCUS Study. Digestive Diseases and Sciences 67:9, pages 4525-4532.
Crossref
Crossref
Alina Ecaterina Jucan, Otilia Gavrilescu, Mihaela Dranga, Iolanda Valentina Popa, Bogdan Mircea Mihai, Cristina Cijevschi Prelipcean & Cătălina Mihai. (2022) Ischemic Heart Disease in Patients with Inflammatory Bowel Disease: Risk Factors, Mechanisms and Prevention. Life 12:8, pages 1113.
Crossref
Crossref
Ni Tien, Tien-Yuan Wu, Cheng-Li Lin, Chia-Jui Wu, Chung-Y Hsu, Yi-Jen Fang & Yun-Ping Lim. (2022) Impact of Inflammatory Bowel Disease (IBD) and IBD Medications on Risk of Hyperlipidemia and in vitro Hepatic Lipogenic-Related Gene Expression: A Population-Based Cohort Study. Frontiers in Medicine 9.
Crossref
Crossref
Nadia Calabriso, Marika Massaro, Egeria Scoditti, Tiziano Verri, Amilcare Barca, Carmela Gerardi, Giovanna Giovinazzo & Maria Annunziata Carluccio. (2022) Grape Pomace Extract Attenuates Inflammatory Response in Intestinal Epithelial and Endothelial Cells: Potential Health-Promoting Properties in Bowel Inflammation. Nutrients 14:6, pages 1175.
Crossref
Crossref
Yan Cao, Malihe Noori, Marziyeh Nazari, Andrew Ng Kay Lup, Alireza Soltani, Vahid Erfani-Moghadam, Aref Salehi, Mehrdad Aghaei, Md Lutfor Rahman, Mohd Sani Sarjadi, Shaheen M. Sarkar & Chia-Hung Su. (2022) Molecular docking evaluation of celecoxib on the boron nitride nanostructures for alleviation of cardiovascular risk and inflammatory. Arabian Journal of Chemistry 15:1, pages 103521.
Crossref
Crossref
Juliana Setyawan, Fan Mu, Miriam L. Zichlin, Emma Billmyer, Nathaniel Downes, Hongbo Yang, Nassir Azimi, Vibeke Strand & Andres Yarur. (2021) Risk of Thromboembolic Events and Associated Healthcare Costs in Patients with Inflammatory Bowel Disease. Advances in Therapy 39:1, pages 738-753.
Crossref
Crossref
Olga Iu. Mironova, Mariia A. Isaikina & Sofiia A. Khasieva. (2021) Аtherosclerosis and cardiovascular risk in patients with inflammatory bowel disease. Terapevticheskii arkhiv 93:12, pages 1533-1538.
Crossref
Crossref
Ekaterina A. Polyakova, Evgeny N. Mikhaylov, Michael M. Galagudza & Evgeny V. Shlyakhto. (2021) Hyperleptinemia results in systemic inflammation and the exacerbation of ischemia-reperfusion myocardial injury. Heliyon 7:11, pages e08491.
Crossref
Crossref
Jasmijn A. M. Sleutjes, Jeanine E. Roeters van Lennep, Eric Boersma, Luis A. Menchen, Matthias Laudes, Klaudia Farkas, Tamás Molnár, Nicholas Alexander Kennedy, Marieke J. Pierik, C. Janneke Woude & Annemarie C. Vries. (2021) Systematic review with meta‐analysis: effect of inflammatory bowel disease therapy on lipid levels. Alimentary Pharmacology & Therapeutics 54:8, pages 999-1012.
Crossref
Crossref
Jacob T. Bjerrum, Yulan L. Wang, Jakob B. Seidelin & Ole H. Nielsen. (2021) IBD metabonomics predicts phenotype, disease course, and treatment response. eBioMedicine 71, pages 103551.
Crossref
Crossref
Preetika Sinh & Raymond Cross. (2021) Cardiovascular Risk Assessment and Impact of Medications on Cardiovascular Disease in Inflammatory Bowel Disease. Inflammatory Bowel Diseases 27:7, pages 1107-1115.
Crossref
Crossref
Machteld Sillen & Paul J. Declerck. (2021) Thrombin Activatable Fibrinolysis Inhibitor (TAFI): An Updated Narrative Review. International Journal of Molecular Sciences 22:7, pages 3670.
Crossref
Crossref
Yu. O. Shulpekova, V. U. Ablaev & I. V. Damulin. (2021) Neurological presentations of inflammatory bowel diseases. Medical alphabet:3, pages 34-42.
Crossref
Crossref
Natalia Kurilenko, Aliia R. Fatkhullina, Aleksandra Mazitova & Ekaterina K. Koltsova. (2021) Act Locally, Act Globally—Microbiota, Barriers, and Cytokines in Atherosclerosis. Cells 10:2, pages 348.
Crossref
Crossref
Matthias Hübenthal, Britt-Sabina Löscher, Jeanette Erdmann, Andre Franke, Damian Gola, Inke R. König & Hila Emmert. (2021) Current Developments of Clinical Sequencing and the Clinical Utility of Polygenic Risk Scores in Inflammatory Diseases. Frontiers in Immunology 11.
Crossref
Crossref
Davide Chicco & Giuseppe Jurman. (2021) Arterial Disease Computational Prediction and Health Record Feature Ranking Among Patients Diagnosed With Inflammatory Bowel Disease. IEEE Access 9, pages 78648-78657.
Crossref
Crossref
Ekaterina Polyakova, Evgeny N. Mikhaylov, Michael M. Galagudza & Evgeny V. Shlyakhto. (2021) Hyperleptinemia Results in Systemic Inflammation and the Exacerbation of Ischemia-Reperfusion Myocardial Injury: The Involvement of the JAK/STAT Pathway. SSRN Electronic Journal.
Crossref
Crossref